Skip to content
OpenCapital
Get started

Denali Therapeutics Inc. DNLI Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
107.7M-3.1%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
100.6M+4.5%
Viking Therapeutics logo
Viking TherapeuticsVKTX
115.6M+3.1%
uniQure logo
uniQureQURE
62.7M+18.1%
Biogen logo
BiogenBIIB
148.4M+1.2%

Other financials

Income statement

See full
Revenue-—
Operating income-$137.4M+5.6%
Net income-$128.4M+3.4%
EPS (diluted)-$0.69+11.5%

Balance sheet

See full
Cash & equivalents$390.7M+551%
Total debt$40.0M-22.3%
Total equity$926.1M-17.5%
Total assets$1.3B-0.4%

Cash flow

See full
Operating cash flow-$131.2M+0.2%
CapEx$2.5M-51.4%
Free cash flow-$133.7M+2.1%

Valuation

See full
Market cap$3.93B+54.2%

Profitability

See full
Operating margin-37,938%-37,986pp
Net margin-33,121.9%-33,159pp
FCF margin-31,736.3%-31,830pp

Returns & leverage

See full
Return on equity-49.6%+34.2pp
Debt / equity0×0.0×
Current ratio9.3×-0.3×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Denali Therapeutics Inc.'s shares (diluted)?
Denali Therapeutics Inc. (DNLI) reported shares (diluted) of 186.6M in Q1 2026.
How has Denali Therapeutics Inc.'s shares (diluted) changed year-over-year?
Denali Therapeutics Inc.'s shares (diluted) increased by 9.0% year-over-year, from 171.2M to 186.6M.
What is the long-term trend for Denali Therapeutics Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Denali Therapeutics Inc.'s shares (diluted) has grown at a 9.1% compound annual growth rate (CAGR), from 485.4M to 687.7M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.